| Kristen Sheffield, MOT, OTR/L | |
|
1600 Gordon Ave, Charlottesville, VA 22903-1918 | |
| (765) 730-9757 | |
| (888) 965-0741 |
| Full Name | Kristen Sheffield |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1600 Gordon Ave, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073231056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119007372 (Virginia) | Primary |
| Provider Name | Martha Jefferson House |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1093445165 PECOS PAC ID: 6406236967 Enrollment ID: O20220630002101 |
News Archive
States around the nation are examining the health reform law for its impact on their residents' health and their budgets' bottom lines.
Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. The majority of those procedures are open-heart operations that require a major incision in the chest. Now, after a six-year study, surgeons at the University of Maryland Medical Center in Baltimore conclude that minimally invasive mitral valve repair techniques, through only a two-inch incision in the right side of the chest, are safe, durable and effective. The results are published in the September 2009 Annals of Surgery.
CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.
Vical Incorporated today reported financial results for the quarter ended March 31, 2010. Revenues were $1.5 million for the first quarter of 2010 compared with $2.3 million for the first quarter of 2009, reflecting lower revenues under the company's license agreement with AnGes MG, Inc. Operating expenses were $10.1 million for the first quarter of 2010 compared with $10.6 million for the first quarter of 2009.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Sheffield, MOT, OTR/L 1600 Gordon Ave, Charlottesville, VA 22903-1918 Ph: (765) 730-9757 | Kristen Sheffield, MOT, OTR/L 1600 Gordon Ave, Charlottesville, VA 22903-1918 Ph: (765) 730-9757 |
News Archive
States around the nation are examining the health reform law for its impact on their residents' health and their budgets' bottom lines.
Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. The majority of those procedures are open-heart operations that require a major incision in the chest. Now, after a six-year study, surgeons at the University of Maryland Medical Center in Baltimore conclude that minimally invasive mitral valve repair techniques, through only a two-inch incision in the right side of the chest, are safe, durable and effective. The results are published in the September 2009 Annals of Surgery.
CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.
Vical Incorporated today reported financial results for the quarter ended March 31, 2010. Revenues were $1.5 million for the first quarter of 2010 compared with $2.3 million for the first quarter of 2009, reflecting lower revenues under the company's license agreement with AnGes MG, Inc. Operating expenses were $10.1 million for the first quarter of 2010 compared with $10.6 million for the first quarter of 2009.
› Verified 1 days ago
Rebecca A Kaufman, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1622 Timberwood Blvd Ste And211, Charlottesville, VA 22911 Phone: 434-202-2830 Fax: 434-529-8457 | |
Physical Therapy At Acac Hand Clinic Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 410 Albemarle Sq, Charlottesville, VA 22901 Phone: 434-817-4278 Fax: 434-817-4279 | |
Caitlin Anzalone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1102 Rose Hill Dr, Charlottesville, VA 22903 Phone: 434-979-8628 Fax: 434-979-8536 | |
Onae A Harris, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1102 Rose Hill Dr, Charlottesville, VA 22903 Phone: 434-979-8628 Fax: 434-979-8536 | |
Cynthia A Stabenow, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2050 Abbey Rd, Suite B, Charlottesville, VA 22911 Phone: 434-244-0069 Fax: 434-296-0067 | |
Mary J. Bridle, MA, OTL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 696 Berkmar Cir, Charlottesville, VA 22901 Phone: 434-817-4100 Fax: 434-817-4101 | |
Ms. Jane Bielefeld, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 123 Buckingham Cir, Charlottesville, VA 22903 Phone: 434-293-9009 Fax: 434-293-8976 |